Navigation Links
3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010

SHENYANG, China, May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the first quarter ended March 31, 2010 on May 16, 2010 at 8:00pm (Eastern).

Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on May 17, 2010 to discuss its 2010 first quarter financial results and recent business activity.

    The conference call may be accessed using the dial-in numbers below:

    Conference ID: 74760426

    Local dial-in:
    China - landline 800 819 0121
    China - mobile 400 620 8038
    Hong Kong - 852 2475 0994

    International toll-free dial-in:
    Hong Kong 800 930 346
    United Kingdom 080 8234 6646
    United States 1 866 519 4004
    International toll dial-in: 65 6723 9381

A telephone replay will be available two hours after the call until May 24, 2010 at:

    International dial-in: +61-2-8235-5000
    United States dial-in: 1-866-214-5335
    Replay- Conference ID: 74760426


A live webcast of the conference will be available on the investor relations page of 3SBio's website at and at . A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at

    Investor Contacts

     Bo Tan
     Chief Financial Officer
     3SBio Inc.
     Tel:   +86-24-2581-1820

     Tom Folinsbee
     Director of Investor Relations
     3SBio Inc.
     Tel:   +852-8191-6991

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 3SBio Announces Changes to its Board of Directors
2. 3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
3. 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
4. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
5. 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
6. 3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
7. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
8. 3SBio Inc. Announces Unaudited Third Quarter 2009 Results
9. 3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
10. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
11. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
Breaking Biology Technology:
(Date:6/21/2016)... June 21, 2016 NuData Security announced today ... role of principal product architect and that ... of customer development. Both will report directly to ... The moves reflect NuData,s strategic growth in its ... high customer demand and customer focus values. ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... ...
Breaking Biology News(10 mins):